Loring Wolcott & Coolidge Fiduciary Advisors’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,936
Closed -$580K 589
2026
Q1
$580K Hold
3,936
0.01% 220
2025
Q4
$612K Sell
3,936
-1,764
-31% -$264K 0.01% 219
2025
Q3
$832K Buy
+5,700
New +$771K 0.01% 190
2023
Q4
Sell
-825
Closed -$105K 611
2023
Q3
$105K Buy
+825
New +$110K ﹤0.01% 351
2018
Q4
Sell
-2,355
Closed -$224K 732
2018
Q3
$224K Hold
2,355
﹤0.01% 258
2018
Q2
$197K Sell
2,355
-7,083
-75% -$587K ﹤0.01% 276
2018
Q1
$768K Buy
9,438
+2,553
+37% +$217K 0.01% 178
2017
Q4
$569K Hold
6,885
0.01% 194
2017
Q3
$563K Buy
+6,885
New +$553K 0.01% 191

Other funds holding XLV

Loring Wolcott & Coolidge Fiduciary Advisors's XLV Position: Q2 2026 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q2 2026, closing a stake of 3,936 shares — an estimated $580K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in XLV in Q3 2017 and held it in 9 quarters. The position peaked at $832K in Q3 2025. 1,292 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q2 2026 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 3,936 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $580K.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in State Street Health Care Select Sector SPDR ETF in Q3 2017 and held it in 9 quarters.
  • Loring Wolcott & Coolidge Fiduciary Advisors's State Street Health Care Select Sector SPDR ETF position peaked at $832K in Q3 2025.
  • 1,292 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.